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Memory T cells, including the well-known CD4
 
 
 
 and CD8
 
 
 
 T cells, are central components of 
the acquired immune system and are the basis for successful vaccination. After infection, 
CD4
 
 
 
 and CD8
 
 
 
 T cells expand into effector cells, and then differentiate into long-lived 
memory cells. We show that a rare population of CD4
 
 
 
CD8
 
 
 
CD3
 
 
 
  
 
 
 
  
 
 
 
NK1.1
 
 
 
 T cells 
has similar functions. These cells potently and specifically inhibit the growth of the 
intracellular bacteria 
 
Mycobacterium tuberculosis
 
 (
 
M. tb.
 
) or 
 
Francisella tularensis
 
 Live 
Vaccine Strain (LVS) in macrophages in vitro, promote survival of mice infected with these 
organisms in vivo, and adoptively transfer immunity to 
 
F. tularensis
 
 LVS. Furthermore, these 
cells expand in the spleens of mice infected with 
 
M. tb.
 
 or 
 
F. tularensis
 
 LVS, and then 
acquire a memory cell phenotype. Thus, CD4
 
 
 
CD8
 
 
 
 T cells have a role in the control of 
intracellular infection and may contribute to successful vaccination.
 
Mycobacterium tuberculosis
 
 (
 
M. tb.
 
) is one of the
leading causes of death by infectious disease
worldwide (1). In contrast, 
 
Francisella tularensis
 
is not a major public health problem, but virulent
strains cause an acute febrile illness with a high
mortality rate, and 
 
F. tularensis 
 
is classified as a
category A bioterrorism agent (2). Vaccine op-
tions for both tularemia and tuberculosis are
limited, and further studies of the immune
responses to these intracellular organisms are
essential to facilitate the development of new
vaccines.
CD4
 
 
 
, CD8
 
 
 
, and TCR 
 
  
 
 
 
 T cells are
well-characterized T cell populations that re-
spond to intracellular pathogens (3). Several
features of T cells define their response to an
invading pathogen. Upon an initial antigen
encounter, naive T cells expand into a large
effector cell population, of which some possess
cytotoxic activities and produce essential mac-
rophage-activating cytokines, such as IFN-
 
 
 
and TNF. These effector T cell activities work
to limit the growth of the pathogen within its
host cell. After the peak of the T cell response,
a small subset of effector cells survives and de-
velops into a long-lived memory population.
These memory cells can react rapidly to a sec-
ond antigen encounter and are essential for
successful vaccination.
Studies of these three major T cell subpop-
ulations in both 
 
M. tb.
 
 and 
 
F. tularensis
 
 Live
Vaccine Strain (LVS) infections have estab-
lished roles for each in both infections (1, 4,
5). Aerosol infection of mice with 
 
M. tb.
 
 re-
sults in a lung disease accompanied by bacterial
dissemination to other organs of the reticu-
loendothelial system, i.e., lymph nodes, spleen,
and liver. In all tissues, development of 
 
M. tb.–
 
specific CD4
 
 
 
 T cells appears critical in limiting
further bacterial growth; a chronic infection
ensues that is rapidly fatal if CD4
 
 
 
 T cells are
removed. CD8
 
 
 
 T cells are also important,
particularly in the later stages of infection,
whereas the contributions of TCR 
 
  
 
 
 
 T cells
are subtle (1, 6, 7). The relative importance of
each T cell subpopulation in murine infection
has clear parallels in human infection (1, 8). In
contrast to chronic 
 
M. tb.
 
 infection, infection
of mice with LVS results in either clearance
and survival, or death, depending on the route
of introduction: the i.p. LD
 
50
 
 is essentially 1
bacterium, but when given subcutaneously or
intradermally (i.d.), the LD
 
50
 
 is much higher,
on the order of 10
 
6
 
 bacteria (4, 9, 10). Survival
of a sublethal primary i.d. infection consistently
leads to very strong and easily measurable spe-
cific protective immunity against a secondary
lethal i.p. challenge. Similar to 
 
M. tb.
 
 infection,
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CD4
 
 
 
, but also CD8
 
 
 
, T cells contribute to resolution of
primary i.d. infection, as well as to protection against sec-
ondary challenge (5, 11).
In contrast to the well-known CD4
 
 
 
 and CD8
 
 
 
 T cell
subpopulations, CD4
 
 
 
CD8
 
 
 
 double negative (DN) T cells
comprise a mixed population of cells that are found in small
numbers in WT mice. A subset of this DN T cell population
is TCR
 
  
 
 
 
CD3
 
 
 
Thy1
 
 
 
, and some cells lack expression of
NK1.1 and TCR
 
 
 
  
 
 markers (12). Previous studies in both
rodents and humans have described alternative non-CD4,
non-CD8 
 
 
 
/
 
 
 
 
 
 T cells, particularly in autoimmune syn-
dromes (13, 14) or KO mice (15, 16), but the biological role
of such DN T cells is unclear. We (5) and others (11) ob-
served the presence of a CD4
 
 
 
CD8
 
 
 
Thy1
 
 
 
 population dur-
ing in vivo 
 
F. tularensis 
 
and 
 
Listeria monocytogenes 
 
infections
(17), prompting our further interest. Our previous in vitro
studies, using a culture system designed to measure the im-
pact of LVS-immune T cells on intracellular bacterial growth,
suggested activity for CD4
 
 
 
CD8
 
 
 
Thy1
 
 
 
 cells that were
TCR 
 
  
 
 
 
 (12). Here we further investigate in detail the role
of this DN T cell subset in immune responses to infections
with LVS, as well as 
 
M. tb.
 
 We show that DN T cells are po-
tent effector cells that expand after infection with 
 
F. tularensis
 
and 
 
M. tb.
 
, can control the intracellular growth of these or-
ganisms, and acquire a memory cell phenotype after the con-
traction phase of the T cell response. These findings demon-
strate a previously unappreciated role for this DN T cell
subset in in vivo protection against intracellular infections.
 
RESULTS
Pathogen-specific DN T cells control intramacrophage 
growth of LVS and 
 
M. tb.
 
Our previous studies demonstrated that antigen-specific
CD4
 
 
 
CD8
 
 
 
Thy1
 
 
 
 cells control 
 
F. tularensis
 
 LVS growth in
murine BM-derived macrophages (BMMØs) in vitro, sug-
gesting T cell-related functions rather than NKT cell–like
functions (12). To further characterize the role of DN cells
during LVS infection, as well as other intracellular infections
such as tuberculosis, we isolated these cells from the spleens
of mice infected with either 
 
M. tb.
 
 or LVS and compared
their ability to inhibit intramacrophage growth of bacteria
using an in vitro culture system. The culture system used for
these experiments was designed to detect the ability of im-
mune cells to limit the growth of intracellular bacteria in
their preferred host cells, i.e., primary resting macrophages.
Of note, only immune T cells have activity in both the LVS
and 
 
M. tb.
 
 culture systems, and most if not all bacterial
growth occurred inside cells (18, 19). Mice immune to ei-
ther LVS or 
 
M. tb.
 
 were depleted in vivo of CD4
 
 
 
, CD8
 
 
 
,
NK1.1
 
 
 
, and TCR
 
 
 
  
 
 
 
 cells before harvest of splenocytes,
and the remaining cells were further purified to yield a
Thy1
 
 
 
CD4
 
 
 
CD8
 
 
 
NK1.1
 
 
 
B220
 
 
 
TCR
 
  
 
 
 
 T cell popula-
tion (DN T cells; see Materials and methods). These Thy1
 
 
 
cells were predominantly (
 
 
 
80–90%) TCR
 
  
 
 
 
CD3
 
 
 
 (see
Fig. 3), and also lacked expression of the NKT cell marker
DX5 (not depicted). The small number of contaminating
Figure 1. Control of F. tularensis LVS and M. tb. macrophage in-
tracellular growth by DN T cells in vitro. BMMØs from WT mice were in-
fected with LVS at an MOI of 1:20 (bacterium/macrophage) or with M. tb. at an 
MOI of 1:100. Infected BMMØs were co-cultured with splenocytes from unin-
fected mice (naive spleen); splenocytes from C57BL/6J mice infected intrader-
mally with LVS 4 wk earlier (a) or with M. tb. by aerosol 4 wk earlier (b, immune 
spleen); highly enriched DN T cells (prepared as described in Materials and 
methods) from LVS-immune or M. tb.–immune spleens; or no spleen cells 
(BMMØ   LVS or M. tb.). Immediately after infection of the BMMØs, spleno-
cytes were added to the indicated wells at a ratio of 1:2 (splenocyte/BMMØ). 
3 d (LVS) or 8 d (M. tb.) after infection, BMMØs were washed, lysed, and plated 
to determine the levels of intracellular bacteria. Values shown are the mean 
numbers of CFU/ml   the SEM of viable bacteria (triplicate samples). Bacterial 
uptake by the BMMØs was determined to be log10 2.040   0.154 CFU/ml (LVS) 
and 3.441   0.200 CFU/ml (M. tb.) at time 0. These data are representative of 
eight (a) or five (b) experiments of similar design. *, P   0.001 compared with 
co-cultures containing naive spleen cells. (c–f) Supernatants from triplicate 
samples obtained from LVS co-cultures (black bars) or M. tb. co-cultures (gray 
bars) immediately before macrophage lysis from the indicated cultures were 
assessed by ELISA for IL-12, IFN- , or TNF- , or by Griess reaction as an indi-
rect measure of NO. Values shown in panels c–e are mean pg/ml   SEM of 
cytokine. Values shown in panel f are mean  mol/ml   SEM of NO. JEM VOL. 202, July 18, 2005 311
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Thy1  cells consisted of macrophages, neutrophils, and
granulocytes; none of these cells exhibit anti-LVS or anti–M.
tb. activities in these in vitro systems (18, 19). As seen previ-
ously (12), co-culture of highly enriched LVS-immune DN
T cells with LVS-infected BMMØs resulted in a significant
(P   0.001) inhibition of LVS growth as compared with na-
ive splenocytes (Fig. 1 a). Similarly, M. tb.–immune DN T
cells significantly inhibited M. tb. intramacrophage growth
(P   0.001 as compared with naive splenocytes) with a mag-
nitude similar to the control provided by whole M. tb.–
immune splenocytes (Fig. 1 b). Investigation of the specific-
ity of DN T cells isolated from M. tb.–immune, LVS-immune,
and  L. monocytogenes–immune mice in the LVS and M.tb
BMMØ co-culture systems revealed that DN T cells only
inhibit intramacrophage growth of the organism for which
they were primed (Fig. 2, a and b). DN T cells were ob-
tained from L. monocytogenes–immune mice as a specificity
control; i.e, an immune population derived from an intracel-
lular bacterial infection but with no known antigens in com-
mon with M. tb. or LVS. Thus, DN T cells contributed to in
vitro control of both murine tuberculosis and LVS infection
in a pathogen-specific manner.
To investigate the cytokine response generated by DN T
cells, cytokine and nitric oxide (NO) levels in the co-culture
supernatants were examined (Fig. 1, c–f ). In both the LVS
and M. tb. co-cultures, supernatants from infected macro-
phages alone, or cultures containing naive splenocytes, had low
to undetectable levels of IFN- , TNF- , IL-12, and NO. In
contrast, cultures containing whole primed splenocytes or
purified DN T cells contained high levels of these factors;
in repeated experiments, the levels of these factors were
roughly comparable between cultures containing whole
primed splenocytes, enriched T cells, and purified DN T
cells. Levels of IL-10 and IL-4 were below the limit of de-
tection. Thus, DN T cells in both the LVS and M. tb. co-
cultures are Th1-like.
As the DN T cells commonly copurified with a small
TCR   Thy1  population, we used flow cytometry to sort
these two populations from LVS-immune splenocytes (Fig.
Figure 2. DN T cell specificity: assessment of the ability of DN 
T cells isolated from immune and nonimmune sources to control 
bacterial intracellular growth. Highly enriched DN T cells were prepared 
from LVS-immune, M. tb.–immune, L. monocytogenes–immune, or naive 
mice. The enriched DN T cell populations were co-cultured with BMMØs 
infected with either F. tularensis LVS (a) or M. tb. (b). Bacterial growth was 
determined as described in Fig. 1. Values shown are the mean numbers of 
CFU/ml   the SEM of viable bacteria (triplicate samples). Bacterial uptake 
by the BMMØs was determined to be log10 1.318   0.275 CFU/ml (LVS) 
and 2.448   0.114 CFU/ml (M. tb.) at time 0. These data are representative 
of two experiments of similar design. *, P   0.01 (a) and P   0.05 com-
pared with co-cultures containing naive spleen cells.
Figure 3. Highly purified LVS-immune DN T cells control the intra-
cellular growth of F. tularensis LVS. Enriched DN T cells from LVS-immune 
mice were prepared as in Fig. 1. The resulting cells were labeled with a 
panel of fluorescently labeled antibodies to cell surface markers and 
further selected via flow sorting on the basis of their expression of both 
TCR   and Thy 1.2, as well as their lack of expression of CD4, CD8, TCR  , 
NK1.1, B220, and CD11b. In this experiment, 81–83% of the enriched cells 
expressed Thy1.2 before sorting (a and b); after sorting, the purified cells 
were 99.6% positive for both TCR   and Thy1.2 (c). To compare the func-
tion of the enriched and purified DN T cells, these cells were co-cultured 
with LVS-infected BMMØs (d). BMMØ co-cultures contained splenocytes 
from either uninfected mice (naive spleen); highly enriched LVS-immune 
DN T cells (presort); DN T cells purified by flow sorting (TCR  Thy1 ); or 
no spleen cells (BMMØ   LVS). Bacterial growth was determined as 
described in Fig. 1. Values shown are the mean numbers of CFU/ml   the 
SEM of viable bacteria (triplicate samples). Bacterial uptake by the BMMØs 
was determined to be log10 1.52   0.187 CFU/ml at time 0. *, P   0.01 
compared with co-cultures containing naive spleen cells.DN T CELLS CONTROL MURINE TULAREMIA AND TUBERCULOSIS | Cowley et al. 312
3, a–c) and examined their ability to control LVS growth in
BMMØs in vitro (Fig. 3 d). These highly purified TCR
    DN T cells ( 99% CD3 Thy1 ) also significantly
controlled (P   0.01) LVS growth, with a magnitude similar
to the starting DN T cell population (Fig. 3 d).
Mechanisms used by DN T cells to control M. tb. and LVS 
intracellular growth
To characterize the mechanisms used by DN T cells to con-
trol LVS and M. tb. intracellular growth, we co-cultured
LVS-immune or M. tb.–immune WT DN T cells with in-
fected BMMØs obtained from WT IFN- R KO, TNFR 1/2
KO, iNOS KO, and P2X7R KO mice (Fig. 4, a and b).
The uptake of either LVS or M. tb. bacteria was comparable
in all types of macrophages (see legend to Fig. 4). In the
LVS-immune DN T cell co-cultures, partial but significant
loss of LVS growth control was observed in co-cultures con-
taining IFN- R KO, TNFR 1/2 KO, and iNOS KO BM-
MØs as compared with WT BMMØs (P   0.05), but not
P2X7R KO BMMØs (P  0.05). Similarly, in the M. tb.–
immune DN T cell co-cultures, significant loss of control of
M. tb. growth was observed in the IFN- R KO and TNFR
1/2 KO BMMØs as compared with WT BMMØs (P  
0.05). In repeated experiments, the magnitude of M. tb. and
LVS growth inhibition in the TNFR 1/2 KO and iNOS
KO BMMØ cultures was variable; for both pathogens, loss
of growth control was significant (P   0.05) in some experi-
ments and not significant in others. In contrast, loss of M. tb.
and LVS growth inhibition was significant in all experiments
for the IFN- R KO BMMØ cultures.
DN T cells contribute to control of intracellular 
infections in vivo
We next investigated the ability of DN T cells to control
primary in vivo LVS infection in the absence of all other T
cell types. Before and throughout a primary sublethal LVS
infection, groups of mice were depleted in vivo of either all
Thy1  T cells or CD4 , CD8 , NK1.1 , and TCR    
cells (antibody combination); thus, DN T cells are the only
known T cell subpopulation remaining after the latter treat-
ment. Of note, previous studies indicate that T cells are ab-
solutely required for the clearance of sublethal LVS infec-
tion, and B cells, macrophages, DCs, and neutrophils are
insufficient (4, 20–23). Survival of mice and growth of LVS
in the organs of the depleted mice were compared with that
of PBS-treated mice (Fig. 5 a). By day 7, a significant (P  
0.01) difference in spleen bacterial burdens was evident be-
tween the Thy1 -depleted mice and the other two treat-
ment groups (antibody combination and PBS mice). The
Thy1 -depleted mice succumbed to the infection, with a
mean survival time of 11.8   1.2 d. In contrast, both the
PBS-treated and antibody combination–treated mice sur-
vived for the duration of the experiment (68 d). Further-
more, although the PBS-treated mice had no detectable bac-
terial burden in their organs by day 21 after infection, the
Figure 4. LVS or M. tb.–immune DN T cells control the intracellu-
lar growth of F. tularensis LVS and M. tb. in part by production 
of IFN-  and TNF- . BMMØs from WT mice, IFN- R KO mice, TNFR 1/2 
KO mice, iNOS KO mice, or P2X7R KO mice (as indicated by the respec-
tive shaded bars) were infected with LVS at an MOI of 1:20 (bacterium/
macrophage) or with M. tb. at an MOI of 1:100. The indicated infected 
BMMØs were co-cultured with highly enriched WT DN T cells (prepared 
as described in Materials and methods) from LVS-immune spleens (a), 
M. tb.–immune spleens (b), or no spleen cells (a, BMMØ   LVS and b, 
BMMØ   M. tb.). 3 d (LVS) or 8 d (M. tb.) after infection, BMMØs were 
washed, lysed, and plated to determine the levels of intracellular bacte-
ria. Values shown are the mean numbers of CFU/ml   the SEM of viable 
bacteria (triplicate samples). LVS uptake by the different BMMØ mono-
layers at time 0 was as follows: log10 1.401   0.174 CFU/ml (WT), 
log10 1.492   0.199 CFU/ml (IFN- R KO), log10 1.46   0.151 CFU/ml 
(TNFR 1/2 KO), log10 1.360   0.102 CFU/ml (iNOS KO), and log10
1.360   0.318 CFU/ml (P2X7R KO). M. tb. uptake for the different 
BMMØ monolayers at time 0 was as follows: log10 3.367   0.096
CFU/ml (WT), log10 3.390   0.154 CFU/ml (IFN- R KO), log10 3.284   
0.255 CFU/ml (TNFR 1/2 KO), log10 3.340   0.297 CFU/ml (iNOS KO),
and log10 3.465   0.061 CFU/ml (P2X7R KO). In all cases, bacterial
uptake in the KO BMMØs was not significantly different from their WT 
counterparts (P   0.20). These data are representative of three (a and 
b) experiments of similar design. *, P   0.05 compared with co-cultures 
containing macrophages   LVS;  , P   0.05 compared with co-cul-
tures containing DN T cells and WT BMMØs.JEM VOL. 202, July 18, 2005 313
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antibody combination–depleted mice exhibited a chronic
infection for the entire treatment period (68 d; Fig. 5 a).
Thus, during a primary sublethal LVS infection, DN T cells
controlled bacterial growth and promoted survival, but were
unable to completely eliminate infection from tissues.
Unlike LVS infection of WT mice, which is cleared
within 3–4 wk, murine tuberculosis is chronic (1). Mice de-
ficient in either CD4  or CD8  T cells exhibit greatly in-
creased susceptibility to M. tb. as compared with WT mice,
indicating that both cell types are essential for resistance to
primary infection (1). To examine the ability of DN T cells
to control an M. tb. infection in the absence of other T cell
types, mice were given a 102-CFU aerosol M. tb. Erdman
challenge. 2 wk after infection, mice were depleted in vivo
of either all Thy1  T cells or CD4 , CD8 , NK1.1  and
TCR     cells. Survival of mice and growth of M. tb. in the
organs of depleted mice were compared with that of PBS-
treated mice. By day 28, both the Thy1 -depleted mice and
Figure 5. DN T cells contribute to control of bacterial infection in 
vivo and expand during the course of in vivo bacterial infection. To 
assess the contribution of DN T cells to primary infection, mice were 
treated with either PBS, a combination of antibodies designed to remove 
all T cells except DN T cells (anti-CD4, anti-CD8, anti-NK1.1, and anti–TCR 
  ), or with anti-Thy1.2 to remove all T cells, and then infected with a 
sublethal i.d. dose of LVS (a) or by aerosol with M. tb. (b) Numbers of CFU 
in organs (n   4) were assessed for bacterial burdens at the indicated 
time points (a), or 30 d after aerosol infection (b). In panel a, mice treated 
with anti-Thy1.2 died by day 11, precluding further analysis of that 
group. Values shown are mean numbers of CFU/ml   the SEM of viable 
bacteria. *, P   0.01 compared with CFUs in organs obtained from PBS-
treated mice. To assess the status of responding DN T cells during primary 
infection, mice were infected with a sublethal i.d. dose of LVS (c) or with a 
low aerosol dose of M. tb. (d), and total numbers of the indicated T cell 
populations in spleens ( SEM) of four infected mice were assessed by 
flow cytometry for each time point. In panel c, the numbers of DN T cells 
in normal mice were also compared with the numbers in mice depleted 
of all other T cells before infection (Ab tx, antibody combination). These 
data are representative of three (a and c) or two (b and d) experiments 
of similar design. Black circles, numbers of CD4  T cells; white circles, 
numbers of CD8  T cells; black triangles, numbers of DN T cells in normal 
mice; white triangles, numbers of DN T cells in antibody combination–
treated mice.DN T CELLS CONTROL MURINE TULAREMIA AND TUBERCULOSIS | Cowley et al. 314
the antibody combination–depleted mice exhibited signifi-
cantly (P   0.01) increased lung, liver, and spleen organ
burdens as compared with the PBS-treated mice (Fig. 5 b).
Multicolor immunohistochemistry analyses of sections of
lungs from long-term infected and antibody-depleted mice,
stained with various antibodies to cell surface markers, fur-
ther supported the efficiency of depletion, indicating the ab-
sence of CD4  cells and the presence of the remaining
CD3  cells infiltrating lung tissue (unpublished data). The
PBS-treated mice all survived for  6 mo, when observation
was terminated. Both the Thy1 -depleted and antibody
combination–depleted treatment groups succumbed to the
infection; however, the mean survival time of the Thy1 -
depleted mice was 40   1 d, whereas the antibody combina-
tion–depleted mice had a significantly increased survival
time of 51   3 d (P   0.001). Thus, DN T cells alone were
sufficient to significantly prolong survival.
DN T cells expand and undergo effector to memory cell 
transition during infection
Naive CD4  and CD8  T cells encountering specific anti-
gens expand into effector cell populations. This expansion is
followed by a contraction phase, resulting in a population of
memory T cells (24–26). We therefore wished to determine
whether DN T cells also followed this program of ex-
pansion, contraction, and differentiation into memory cells.
To this end, we followed the absolute numbers of CD4 ,
CD8 , and DN T cells in the spleens of PBS-treated mice
during a sublethal LVS infection; the numbers of DN T cells
in the spleens of antibody combination–depleted mice were
also measured (Fig. 5 c). CD4 , CD8 , and DN T cell pop-
ulations in PBS-treated mice expanded by day 7 after infec-
tion; numbers peaked at day 14, shortly after LVS growth
began to diminish (Fig. 5 c). Flow cytometric analysis re-
vealed that 3.5% of naive DN T cells express CD25 (IL-
2R ), which increased to 35% by day 7 after infection, dur-
ing the expansion phase of the T cell response. This was
followed by an apparent contraction phase for these cells and
concomitant loss of CD25 expression. In this experiment,
CD4 , CD8 , and DN T cell numbers increased in spleens
by approximately six-, three-, and eightfold, respectively,
before returning to their initial levels. In contrast, DN T cell
numbers in antibody combination–depleted mice reached a
peak at day 14 that remained high for the duration of the ex-
periment, which was consistent with the chronic infection
observed in these mice (Fig. 5 a). Interestingly, the numbers
of DN T cells expand in spleens after depletion but before
infection (Fig. 5 c), possibly suggesting homeostatic prolifer-
ation. Expansion of CD4 , CD8 , and DN T cells in the
spleens of normal mice after a low-dose M. tb. aerosol infec-
tion was also evident (Fig. 5 d). Consistent with the slow
growth of M. tb. in the tissues and the chronic nature of the
infection, DN T cell numbers peaked at day 28 after infec-
tion and remained high for the duration of the experiment.
Thus, DN T cells followed a time course of expansion and
contraction similar to CD4  and CD8  T cells in the spleens
of mice infected with either LVS or M. tb.
Changes in expression of other surface markers on CD4 
and CD8  T cells can be used to describe the progression of
cells from naive (CD44lo CD45RBhi CD62Lhi IL-7R hi), to
effector (CD44hi CD45RBhi CD62Llo IL-7R lo), to a mem-
ory cell phenotype (CD44hi CD45RBlo CD62Lhi and lo IL-
7R hi; references 24–26). In particular, recent experiments
indicate an important role for IL-7 in T cell survival, promot-
ing long-term persistence of both naive and memory T cells
through the regulation of apoptosis (27). Here we examined
the expression of these markers on DN T cells during a sub-
lethal LVS infection. Consistent with CD4 and CD8 T cell
experiments, 42% of naive DN T cells expressed IL-7R ,
but this number diminished to only 12% at the peak of the
DN T cell response (day 14 after infection), followed by the
emergence of a larger IL-7R –positive population (32%) by
day 28 (Fig. 6 a). Similarly, CD62L, CD44, and CD45RB
expression on DN T cells followed a pattern consistent with
their development from naive, to effector, and finally to
memory T cells (Fig. 6 a). Thus, DN T cells acquired typical
memory cell surface markers after LVS infection.
We next sought to determine whether DN memory T
cells adoptively transferred immunity in vivo. DN T cells
were isolated from the spleens of LVS-immune mice and
were transferred to naive mice before a lethal LVS i.p. chal-
lenge. Bacterial burdens in spleens were assessed 3 d after
challenge, and survival of the recipient mice was monitored.
The ability of DN memory T cells to transfer immunity was
compared with that of naive splenocytes, whole LVS-
immune splenocytes, and LVS-immune CD4  and CD8  T
cells (Fig. 6 b). Bacterial burdens in spleens and livers of mice
receiving whole LVS-immune splenocytes, CD4 , CD8 ,
and DN T cells were significantly diminished as compared
with mice receiving naive splenocytes (P   0.01). Consis-
tent with these observations, all mice that received CD4 ,
CD8 , or DN LVS-immune T cells survived lethal LVS
challenge, whereas all mice receiving naive cells succumbed
to the infection (Fig. 6 b). These results indicate that DN T
cells functioned as true memory cells in transferring protec-
tive immunity to naive mice.
DISCUSSION
Improvements in vaccine development rely on advances in
our knowledge of the cell types and cytokines that contrib-
ute to protective immunity. For intracellular pathogens,
CD4  and CD8  T cells are considered the primary media-
tors of long-lived protective memory. We show, for the first
time, that another T cell type contributes considerably to in
vivo control of infections with two intracellular pathogens,
M. tb. and F. tularensis LVS. These DN T cells, derived from
LVS and M. tb.–immune mice, are pathogen-specific, Th1-
like T cells expressing TCR    and CD3; importantly, these
cells acquire a memory phenotype after infection. DN T
cells potently control the intracellular growth of M. tb. andJEM VOL. 202, July 18, 2005 315
ARTICLE
Figure 6. DN T cells acquire memory cell markers during primary 
sublethal LVS infection and transfer immunity to LVS in vivo. Mice 
infected with a sublethal i.d. dose of LVS were treated with a combina-
tion of antibodies designed to remove all T cells except DN T cells (anti-
CD4, anti-CD8, anti-NK1.1, and anti–TCR   ). Spleens were removed 
from naive mice (naive) or at the indicated time points after LVS infec-
tion. Splenocytes were labeled with a panel of fluorescent antibodies to 
cell surface markers and gated on the basis of their expression of Thy 
1.2, as well as their lack of expression of CD4, CD8, TCR  , NK1.1, B220, 
and CD11b. This gated DN T cell population was then further assessed by 
flow cytometry for expression of the memory cell markers IL-7R , 
CD62L, CD44, and CD45RB (a). The numbers represent the percentage of 
cells in each population that falls within the designated gate. Red lines, 
isotype control; black lines, antibody-specific staining. Similar results 
were observed using this flow cytometry analysis on mice not depleted 
before analyses. In panel b, enriched CD4 , CD8 , and DN T cells were 
prepared from LVS-immune mice (described in Materials and methods). 
Whole naive and LVS-immune splenocytes were also prepared, and 107 
of each of these cell preparations were adoptively transferred i.p. to 
naive C57/BL6 mice. 2 h later, all mice were given a lethal 102 LVS i.p. 
challenge. Bacterial liver and spleen burdens were determined 3 d after 
infection and are represented as the mean numbers of CFU/organ   the 
SEM of viable bacteria. The number of survivors/total mice for each 
group is also shown. These data are representative of three (a) or two 
(b) experiments of similar design. *, P   0.01 compared with CFUs in 
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LVS in vitro, expand in vivo, and contribute to control of in
vivo infection by several mechanisms, including cytokine
production and possibly cytotoxicity.
In both mice and humans, protective immune responses
to M. tb. and to Francisella depend on cell-mediated immu-
nity provided by T cells and appear to rely heavily on appro-
priate CD4  T cell activity (1, 4). This is clearly illustrated
by the impact of HIV infection and subsequent reduction in
CD4  T cell numbers on susceptibility to tuberculosis (1).
CD8  cells also contribute notably to both infections (1, 4).
The effector mechanisms used by CD4  and CD8  T cells
remain the subject of intense study, but clearly include pro-
duction of IFN-  and TNF-  for the activation of mac-
rophages, leading to production of toxic reactive oxygen and
nitrogen species, as well as classical CD8  T cell cytotoxic
activities (1, 3). We have taken advantage of an in vitro cul-
ture system to further understand the various effector mech-
anisms used by DN T cells. We find that TNF, iNOS, and
especially IFN-  contribute to M. tb. and LVS growth con-
trol by DN T cells (Fig. 4), but other mechanisms that re-
main to be defined are also important. However, stimulation
of macrophage P2X7R by DN T cell products is not a likely
alternative mechanism. Others have presented evidence that
control of latent M. tb. infection in mice is dependent on
IFN-  but independent of iNOS (28). One iNOS-indepen-
dent candidate is LRG-47, a 47-kD guanosine triphos-
phatase family member (29), and another is the recently
identified product of the Ipr1 gene, a putative IFN- –regu-
lated transcriptional cofactor (30). The role of these mole-
cules in the control of LVS and M. tb. intracellular growth
by CD4 , CD8 , and DN T cells is currently under investi-
gation. Preliminary studies indicate LVS-immune DN T
cells derived from perforin KO mice retain anti-LVS activ-
ity, and abrogation of DN T cell FasL function has no im-
pact on anti-LVS activity (unpublished data). Interestingly,
however,  20% and 5% of LVS-immune DN T cells ex-
press intracellular granzyme B on stimulation through CD3
or via LVS-infected BMMØs, respectively (unpublished
data), indicating that these cells possess unconventional cyto-
toxic activity that merits further detailed study.
Current studies are also seeking to determine the devel-
opmental origin and MHC restriction profiles of these DN
T cells, which appear to be complex. The lack of expression
of the NK1.1 and DX5 markers on these cells indicate that
they are very unlikely to be NKT cells. To date, we have
obtained functional DN T cells from LVS-immune class II
KO mice,  2microglobulin KO mice, and CD8 KO mice
(unpublished data), indicating that DN T cell development
and function does not rely exclusively on any one of these
elements. For several reasons, we find it unlikely that these
DN cells arise from normal CD4  or CD8  T cells that have
lost expression of their respective costimulatory molecules
after activation, such as been observed after HIV infection
(31). First, DN T cells were readily detected in and obtained
from normal uninfected mice (see Figs. 2, 5, and 6). Second,
in this study, DN cells expanded in mice that were depleted
of all CD4 and CD8 cells before infection. Third, retrovi-
ruses, in particular, commonly down-regulate their own re-
ceptors, whereas LVS and M. tb. are not known to interact
directly with either CD4 or CD8. However, whether these
cells naturally lost expression of CD4 and CD8 because of
high-avidity TCR signals during thymic development (32,
33) remains to be determined.
Other studies have described DN T cells in a variety of
genetically deficient mice, including TCR transgenic mice
(34), CD4 KO mice (15, 16, 35), and autoimmune syn-
dromes including lpr and FasL-deficient mice (14, 33, 36).
These animals may have expanded or abnormal accumula-
tions of DN T cells as a result of disregulated immune sys-
tems; cells lacking expression of CD4 and/or CD8 in these
mouse models arise as a consequence of the mutation, and do
not reflect normal physiology. There have only been sporadic
descriptions of DN T cells in normal mice. DN T cells that
possess regulatory T cell activities in tissue allograft rejection
models have been described (37, 38); in one case, these cells
acquired and presented alloantigen to syngeneic CD8  T
cells, suppressing their function (38). In addition to these arti-
ficial models, isolated reports previously suggested that DN T
cells in normal mice might contribute to immune responses.
A population of DN T cells proliferates and produces IFN- 
and TNF-  in response to L. monocytogenes (39) and mouse
CMV (40) infections. DN T cells are 70–90% of lymphocytes
in the genital tract of Chlamydia trachomatis–infected mice
(41). However, the few murine descriptions of the presence
of DN T cells have not addressed their biological importance
or determined whether they contribute to memory immune
responses. In humans, DN T cell numbers increase during
staphylococcal toxic shock syndrome (42) and HIV infection
(43, 44) and respond to lipid M. tb. antigens (45, 46). Thus, it
is possible that humans have a similar population with an im-
portant role in immune defense.
We demonstrate that a small DN T cell population is found
in the spleens of normal WT mice before, during, and after in-
tracellular bacterial infections, and that these cells clearly partic-
ipate in control of infection. These experiments unambigu-
ously assign a normal physiological function to cells that were
previously of uncertain utility and consequence. Most impor-
tantly, we show that these cells acquire a memory T cell phe-
notype and, thus, may be a new target for vaccination.
MATERIALS AND METHODS
Bacteria. M. tb. Erdman (originally obtained from the collection of F. Col-
lins, Center for Biologics Evaluation and Research [CBER]/Food and Drug
Administration [FDA], Rockville, MD) was grown and frozen as previously
described (18), as was F. tularensis LVS (29684; American Type Culture Col-
lection; references 4, 12). Viable bacteria were quantified by plating serial di-
lutions on Mueller-Hinton agar or 7H11 plates, respectively.
Animals, infections, and determination of bacterial organ burdens.
Male-specific, pathogen-free C57BL/6J mice, as well as all C57 KO mice
(except P2X7), were purchased from the Jackson Laboratory. P2X7 KO
mice (47) were obtained from C. Gabel (Pfizer, Groton, CT) and bred atJEM VOL. 202, July 18, 2005 317
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CBER/FDA. All animals were housed in a barrier environment at CBER/
FDA, and procedures were performed according to approved protocols un-
der Animal Care and Use Committee guidelines. Throughout, “LVS im-
mune” refers to splenoctyes obtained from mice given a sublethal priming
dose of 104 LVS i.d. 1–3 mo before death. “M. tb. immune” refers to sple-
nocytes obtained from mice given a low-dose aerosol infection of M. tb. Erd-
man using an inhalation exposure system (model A4212; Glas-Col), as pre-
viously described (18), 1–3 mo before death. “L. monocytogenes immune”
refers to splenoctyes obtained from mice given a sublethal priming dose of
103 L. monocytogenes, strain EGD, i.d. or i.p. 1–3 mo before death. Lethal
LVS infections for adoptive transfer studies were given i.p. All materials, in-
cluding bacteria, were diluted in PBS (Cambrex) containing  0.01 ng/ml
endotoxin, including 0.05% Tween 80 for M. tb. The numbers of CFUs
were determined in emulsified organs from infected mice as previously de-
scribed (4, 12, 18), using groups of three to five mice.
In vitro assessment of control of intracellular bacterial growth in
BMMØs. The in vitro culture systems used, and the validation of the cul-
ture systems’ abilities to reflect known parameters of T cell activities during
in vivo control of bacterial growth, have been described in detail elsewhere
(18, 19). In brief, BMMØs were used as the target cells. BM was flushed
from femurs of healthy mice with DMEM (Life Technologies) supple-
mented with 10% heat-inactivated FCS (HyClone), 10% L-929–conditioned
medium, 0.2 mM L-glutamine (Life Technologies), 1 mM Hepes buffer
(Life Technologies), and 0.1 mM nonessential amino acids (Life Technolo-
gies); the resulting mixture was termed complete DMEM (cDMEM). Cells
were washed, and a single-cell suspension was prepared, plated at 106 viable
cells per well in 48-well plates in cDMEM supplemented with 50  g/ml
gentamycin (Life Technologies) and incubated at 37 C in 5% CO2. After
1 d, the medium was replaced with antibiotic-free cDMEM and incubated
for an additional 6 d at 37 C in 5% CO2. The medium was replaced with
fresh, gentamicin-free cDMEM every 2 d during the 7-d incubation.
After the 7-d culture period, the BMMØs formed a confluent mono-
layer, and the concentration of BMMØs was estimated to be 5   106 cells/
well in 48-well plates. BMMØs were then infected with F. tularensis LVS or
M. tb. Erdman according to the following protocol: bacteria were diluted
from frozen stocks in cDMEM and added at a multiplicity of infection
(MOI) of 1:20 (LVS) or 1:100 (M. tb.) bacterium/BMMØ. A low MOI was
chosen to mimic initial in vivo exposure to relatively small numbers of or-
ganisms and permit controlled infection of the macrophage monolayer over
3 d (LVS), or 8 d (M. tb.). These different time points were selected to ac-
commodate the different growth rates of the two organisms and were based
on previous data indicating the respective peaks of bacterial growth that co-
incided with the maximal impact of co-cultured immune cells (18, 19). LVS
or M. tb. was coincubated with BMMØs at 37 C in 5% CO2 for 2 h and
washed three to five times with PBS (Cambrex). The LVS-infected mono-
layers were then incubated for 45 min to 1 h in cDMEM supplemented
with 50  g/ml gentamicin to eliminate extracellular bacteria, and infected
BMMØs were washed extensively. M. tb.–infected monolayers were not
treated with antibiotics, but were washed extensively. After the last wash,
PBS was replaced with 1 ml/well cDMEM, and spleen cells or separated
subpopulations were added to the indicated wells for co-culture. Cultures
were incubated at 37 C in 5% CO2 for the remainder of the experiment.
To determine bacterial uptake, some BMMØs were lysed with sterile dis-
tilled water (LVS) or sterile distilled water containing 0.01% saponin (M.
tb.) for 2–3 min immediately after infection and washing with PBS. Culture
lysates were serially diluted in PBS (LVS) or PBS   0.01% Tween 80 (M.
tb.) and plated on Mueller-Hinton agar (LVS) or 7H11 agar (M. tb.) plates.
Plates were incubated for 2–3 d (LVS) or 3 wk (M. tb.) at 37 C in 5% CO2,
and colonies were counted. The growth of bacteria in BMMØs was further
monitored by lysing cultures at the indicated time points after co-culture,
plating lysates, and counting colonies, as described above.
Viability of the macrophage monolayer was routinely assessed during
this time using both trypan blue exclusion and light microscopy. Macro-
phage monolayers at the end of the 3-d (LVS) or 8-d (M. tb.) incubation
periods exhibited morphological changes consistent with infection; how-
ever, the monolayers were still intact, viable, and adherent (18, 19).
Spleens used for co-culture were aseptically removed from selected
mice and disrupted with a 3-ml syringe plunger. A single-cell suspension
was prepared, and erythrocytes were lysed with ammonium chloride. Cells
were washed, their viability was assessed by exclusion of trypan blue, and
cells were resuspended in Dulbecco PBS–2% FCS to the appropriate con-
centration and added to BMMØ cultures. Unless otherwise stated, 2.5  
106 splenocytes (or their separated subpopulations) were added to the 48-
well cultures ( 1 splenocyte to 2 BMMØs).
 Enrichment of T cell subpopulations (for in vitro co-culture and
in vivo adoptive transfer). DN T cells were enriched using a combina-
tion of in vivo depletion by antibody treatment, in vitro depletion using
MACS beads, and positive selection via MACS beads using a magnetic cell
sorting system (Miltenyi Biotech). This approach is a further refinement of
previously described methods (12). In brief, LVS- or M. tb.–immune mice
were depleted in vivo of CD4 , CD8 , NK1.1 , and TCR     cells before
harvest of spleens (see In vivo depletion...subpopulations section); spleno-
cytes were further depleted in vitro using B220  MACS cell depletion col-
umns, and the remaining DN T cells were obtained using a Thy1.2  MACS
cell enrichment column. Separated and purified cell populations of CD4  or
CD8  T cells were similarly prepared from the respective depleted mice, fol-
lowed by enrichment with the appropriate MACS columns. All separated
subpopulations were analyzed by flow cytometry to determine the purity of
the cells. The purified cells were routinely  80–90% of the intended cell
type; the identity of the other contaminating cells were always accounted for
and included macrophages, neutrophils, or granulocytes that do not have an-
tibacterial activity on the BMMØ monolayer in the in vitro system (18, 19).
Quantitation of cytokines and NO in BMMØ culture supernatants.
Culture supernatants were assayed for IFN- , IL-12, TNF- , and IL-4 by
standard sandwich ELISAs as previously described (12, 18, 19), using reagents
obtained from BD Biosciences and quantified by comparison to recombinant
standards. NO was detected in culture supernatants by the Griess reaction as
previously described (48), using commercial Griess reagent (Sigma-Aldrich).
In vivo depletion of cell subpopulations.  Antibodies for in vivo de-
pletion of CD4  T cells (clone GK1.5), CD8  T cells (clone 2.43), TCR
    T cells (clone GL3), NK1.1  cells (clone PK136), and Thy1.2  cells
(clone 30-H12) were produced as ascites in BALB/c nu/nu mice, precipi-
tated with 50% ammonium sulfate, quantified using a capture ELISA spe-
cific for rat IgG or mouse IgM, and tested for endotoxin levels (Cambrex);
all mAb preparations used in vivo contained  10 EU/ml endotoxin. Anti-
bodies were administered to mice i.p. as previously described (5, 12, 18).
For CD4 , CD8 , and TCR     T cell subpopulations, cell depletions
routinely reduced the depleted cell type to  0.5% detectable remaining
cells in spleens of treated mice. However, the effectiveness of NK1.1  cell
depletion approached 80% and was more variable.
Flow cytometry analysis and sorting. Single cell suspensions were pre-
pared and stained for a panel of murine cell surface markers and analyzed us-
ing a flow cytometer (LSR II; Becton Dickinson) and FACSDiVa BD Bio-
sciences) or FlowJo (Tree Star, Inc.) software, essentially as previously
described (5, 12, 18, 19). Clones used included RM4-5 (anti-CD4), 53-6.7
(anti-CD8a), GL3 (anti–TCR   ), NK1.1 (anti-NK1.1), 53-2.1 (anti-
Thy1.2), H57-597 (anti–TCR  ), 17A2 (anti-CD3), M1/70 (anti-CD11b),
RA3-6B2 (anti–CD45/B220), M1/70 (anti-CD11b), NK1.1 (anti-NK1.1),
DX5 (anti-CD49b), and GL3 (anti–TCR   ). All preceding antibodies, as
well as FcBlock, were obtained from BD Biosciences, and optimal concen-
trations were determined in separate experiments for use in three- to five-
color staining protocols as required using appropriate fluorochrome-labeled
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To assess expansion of CD4 , CD8 , and DN T cell populations,
spleen cells were harvested at the time points after infection specified in the
figures, total cell numbers were counted, and the percentages of CD4  and
CD8  T cells in each spleen were determined. Spleens from LVS-infected
mice were prepared using pressure disruption, whereas spleens from M. tb.–
infected mice were prepared using Stomacher bags for greater biosafety
containment. The latter technique yields slightly fewer total recovered cells,
resulting in slightly lower T cell subpopulation numbers in M. tb. experi-
ments (compare day 0 of Fig. 3 c with d). Spleen cells that were negative for
CD4, CD8, NK1.1, TCR   , B220, and CD11b, but positive for Thy1,
were designated DN T cells, and total cell numbers calculated.
To follow the expression of memory cell markers, LVS-infected mice
were treated in vivo with antibodies specific for the depletion of CD4  T
cells, CD8  T cells, NK1.1  cells, and TCR     cells. All lymphocyte-
gated cells that were negative for CD4, CD8, NK1.1, TCR   , B220, and
CD11b, but positive for Thy1, were considered DN T cells, gated, and an-
alyzed for expression of CD25 (clone PC61), CD44 (clone IM7), CD45RB
(clone C363.16A), CD62L (clone MEL-14), and IL-7R  (clone A7R34).
Purification of DN T cells via sorting was performed at the National
Institute of Allergy and Infectious Diseases (NIAID)/National Institutes of
Health (NIH) Flow Cytometry Facility on a FACStar Plus (Becton Dickin-
son). DN T cells were enriched from LVS-immune mouse spleens as
described in Enrichment of T cell...transfer section. The enriched Thy1 
DN T cell population was further sorted, selecting for cells that were
Thy1 TCR    or Thy1 TCR   , as well as negative for CD4, CD8,
NK1.1, TCR   , and B220.
Adoptive transfer of LVS-immune cell subpopulations.  Spleno-
cytes from LVS-immune mice were prepared and enriched for various T
cell subpopulations, as described in detail in Enrichment of T…transfer sec-
tion, and transferred i.p. to naive C57BL/6J mice and mice challenged i.p.
with a lethal 102 dose of LVS IP. Bacterial burdens were assessed 3 d after
i.p. challenge at the peak of the secondary infection (9, 10, 21), and other
recipient mice were observed for survival of challenge for 30 d.
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